Cargando…

A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years

To explore an appropriate time interval between oocyte retrieval and intracytoplasmic sperm injection (ICSI) for optimal embryological and clinical outcomes in ICSI cycles over 40 years of maternal age. A retrospective analysis of 1476 ICSI fresh cycles from women aged over 40 years, was performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jingbo, Wang, Yanfang, Fang, Cong, Li, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497496/
https://www.ncbi.nlm.nih.gov/pubmed/37699932
http://dx.doi.org/10.1038/s41598-023-41397-7
_version_ 1785105312775143424
author Chen, Jingbo
Wang, Yanfang
Fang, Cong
Li, Tingting
author_facet Chen, Jingbo
Wang, Yanfang
Fang, Cong
Li, Tingting
author_sort Chen, Jingbo
collection PubMed
description To explore an appropriate time interval between oocyte retrieval and intracytoplasmic sperm injection (ICSI) for optimal embryological and clinical outcomes in ICSI cycles over 40 years of maternal age. A retrospective analysis of 1476 ICSI fresh cycles from women aged over 40 years, was performed at the Reproduction Medicine Research Center of the Sixth Affiliated Hospital of Sun Yat-sen University, between December 2013 and August 2020. The fertilization rate and clinical pregnancy rate were the main outcomes. Multivariate linear regression and logistic regression analysis of factors showed that fertilization rate (P = 0.024) and clinical pregnancy rate (P = 0.011) were significantly associated with oocyte pick up (OPU)-ICSI interval. A longer OPU-ICSI interval (no more than 6 h) was associated with a higher fertilization rate but significantly decreased the clinical pregnancy rate when the OPU-ICSI interval was over 4 h (P < 0.05). The optimal OPU-ICSI interval is between 3 and 4 h for excellent embryological and clinical outcomes in ICSI cycles over 40 years of maternal age.
format Online
Article
Text
id pubmed-10497496
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104974962023-09-14 A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years Chen, Jingbo Wang, Yanfang Fang, Cong Li, Tingting Sci Rep Article To explore an appropriate time interval between oocyte retrieval and intracytoplasmic sperm injection (ICSI) for optimal embryological and clinical outcomes in ICSI cycles over 40 years of maternal age. A retrospective analysis of 1476 ICSI fresh cycles from women aged over 40 years, was performed at the Reproduction Medicine Research Center of the Sixth Affiliated Hospital of Sun Yat-sen University, between December 2013 and August 2020. The fertilization rate and clinical pregnancy rate were the main outcomes. Multivariate linear regression and logistic regression analysis of factors showed that fertilization rate (P = 0.024) and clinical pregnancy rate (P = 0.011) were significantly associated with oocyte pick up (OPU)-ICSI interval. A longer OPU-ICSI interval (no more than 6 h) was associated with a higher fertilization rate but significantly decreased the clinical pregnancy rate when the OPU-ICSI interval was over 4 h (P < 0.05). The optimal OPU-ICSI interval is between 3 and 4 h for excellent embryological and clinical outcomes in ICSI cycles over 40 years of maternal age. Nature Publishing Group UK 2023-09-12 /pmc/articles/PMC10497496/ /pubmed/37699932 http://dx.doi.org/10.1038/s41598-023-41397-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Chen, Jingbo
Wang, Yanfang
Fang, Cong
Li, Tingting
A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years
title A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years
title_full A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years
title_fullStr A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years
title_full_unstemmed A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years
title_short A 3–4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years
title_sort 3–4 h oocyte retrieval-icsi interval optimizes clinical outcomes for women over 40 years
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497496/
https://www.ncbi.nlm.nih.gov/pubmed/37699932
http://dx.doi.org/10.1038/s41598-023-41397-7
work_keys_str_mv AT chenjingbo a34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT wangyanfang a34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT fangcong a34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT litingting a34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT chenjingbo 34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT wangyanfang 34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT fangcong 34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years
AT litingting 34hoocyteretrievalicsiintervaloptimizesclinicaloutcomesforwomenover40years